Joyce C Chang1, David S Mandell2, Andrea M Knight1. 1. Perelman School of Medicine, University of Pennsylvania, and the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania. 2. Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
OBJECTIVE: Childhood-onset systemic lupus erythematosus (SLE) is associated with high risk for organ damage, which may be mitigated by early diagnosis and treatment. We characterized health care utilization for youth in the year preceding SLE diagnosis compared to controls. METHODS: Using Clinformatics DataMart (OptumInsight) de-identified administrative data from 2000 to 2013, we identified 682 youth ages 10-24 years with new-onset SLE (≥3 International Classification of Diseases, Ninth Revision codes for SLE 710.0, each >30 days apart), and 1,364 age- and sex-matched healthy controls. We compared the incidence of ambulatory, emergency, and inpatient visits 12 months before SLE diagnosis and frequency of primary diagnoses. We examined subject characteristics associated with utilization preceding SLE diagnosis. RESULTS: Youth with SLE had significantly more visits in the year preceding diagnosis than controls across ambulatory (incidence rate ratio [IRR] 2.48, P < 0.001), emergency (IRR 3.42, P < 0.001), and inpatient settings (IRR 3.02, P < 0.001). The most frequent acute-care diagnoses and median days to SLE diagnosis were: venous thromboembolism (313, interquartile range [IQR] 18-356), thrombocytopenia (278, IQR 39-354), chest pain (73, IQR 29.5-168), fever (52, IQR 17-166), and acute kidney failure (14, IQR 5-168). Having a psychiatric diagnosis prior to SLE diagnosis was strongly associated with increased utilization across all settings. CONCLUSION: Youth with SLE have high health care utilization throughout the year preceding SLE diagnosis. Examining variable diagnostic trajectories of youth requiring acute care preceding SLE diagnosis, and increased attention to psychiatric morbidity, may help improve care for youth with new-onset SLE.
OBJECTIVE: Childhood-onset systemic lupus erythematosus (SLE) is associated with high risk for organ damage, which may be mitigated by early diagnosis and treatment. We characterized health care utilization for youth in the year preceding SLE diagnosis compared to controls. METHODS: Using Clinformatics DataMart (OptumInsight) de-identified administrative data from 2000 to 2013, we identified 682 youth ages 10-24 years with new-onset SLE (≥3 International Classification of Diseases, Ninth Revision codes for SLE 710.0, each >30 days apart), and 1,364 age- and sex-matched healthy controls. We compared the incidence of ambulatory, emergency, and inpatient visits 12 months before SLE diagnosis and frequency of primary diagnoses. We examined subject characteristics associated with utilization preceding SLE diagnosis. RESULTS: Youth with SLE had significantly more visits in the year preceding diagnosis than controls across ambulatory (incidence rate ratio [IRR] 2.48, P < 0.001), emergency (IRR 3.42, P < 0.001), and inpatient settings (IRR 3.02, P < 0.001). The most frequent acute-care diagnoses and median days to SLE diagnosis were: venous thromboembolism (313, interquartile range [IQR] 18-356), thrombocytopenia (278, IQR 39-354), chest pain (73, IQR 29.5-168), fever (52, IQR 17-166), and acute kidney failure (14, IQR 5-168). Having a psychiatric diagnosis prior to SLE diagnosis was strongly associated with increased utilization across all settings. CONCLUSION: Youth with SLE have high health care utilization throughout the year preceding SLE diagnosis. Examining variable diagnostic trajectories of youth requiring acute care preceding SLE diagnosis, and increased attention to psychiatric morbidity, may help improve care for youth with new-onset SLE.
Authors: Wilmer L Sibbitt; John R Brandt; Courtney R Johnson; Marcos E Maldonado; Samir R Patel; Corey C Ford; Arthur D Bankhurst; William M Brooks Journal: J Rheumatol Date: 2002-07 Impact factor: 4.666
Authors: Latisha D Heinlen; Micah T McClain; Joan Merrill; Yasmin W Akbarali; Colin C Edgerton; John B Harley; Judith A James Journal: Arthritis Rheum Date: 2007-07
Authors: Aimee O Hersh; Emily von Scheven; Jinoos Yazdany; Pantelis Panopalis; Laura Trupin; Laura Julian; Patricia Katz; Lindsey A Criswell; Edward Yelin Journal: Arthritis Rheum Date: 2009-01-15
Authors: Joyce C Chang; Rui Xiao; Andrea M Knight; Stephen E Kimmel; Laura M Mercer-Rosa; Pamela F Weiss Journal: Semin Arthritis Rheum Date: 2020-05-03 Impact factor: 5.532
Authors: Scott E Wenderfer; Joyce C Chang; Amy Goodwin Davies; Ingrid Y Luna; Rebecca Scobell; Cora Sears; Bliss Magella; Mark Mitsnefes; Brian R Stotter; Vikas R Dharnidharka; Katherine D Nowicki; Bradley P Dixon; Megan Kelton; Joseph T Flynn; Caroline Gluck; Mahmoud Kallash; William E Smoyer; Andrea Knight; Sangeeta Sule; Hanieh Razzaghi; L Charles Bailey; Susan L Furth; Christopher B Forrest; Michelle R Denburg; Meredith A Atkinson Journal: Clin J Am Soc Nephrol Date: 2021-11-03 Impact factor: 8.237
Authors: Lisa P Spees; Karen Hicklin; Michael C Adams; Laura Farnan; Jeannette T Bensen; Donna B Gilleskie; Jonathan S Berg; Bradford C Powell; Kristen Hassmiller Lich Journal: Genet Med Date: 2022-01-13 Impact factor: 8.864
Authors: Louis Papageorgiou; Haris Alkenaris; Maria I Zervou; Dimitriοs Vlachakis; Ioannis Matalliotakis; Demetrios A Spandidos; George Bertsias; George N Goulielmos; Elias Eliopoulos Journal: Int J Mol Med Date: 2021-11-18 Impact factor: 4.101